• HOME
  •  > 
  • 医療技術
  •  > 
  • 雑誌
  •  >  Rad Fan　18/14　2020年12月臨時増刊号　放射線治療情報BOOK 2020

Rad Fan　18/14　2020年12月臨時増刊号　放射線治療情報BOOK 2020

出版社： メディカルアイ
発行日： 2020-12-21
分野： 医療技術  >  雑誌
ISSN： 13483498
雑誌名：
特集： 放射線治療情報BOOK 2020
電子書籍版： 2020-12-21
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

4,074 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

2,851 円(税込)

購入する

目次

  • 序文
    「高精度放射線治療の実現に向けたアプローチと今後の展望」
    　
    特集1「放射線治療機器の最新技術」
    　Halcyon
    　SyncTraX FX4
    　転移性脳腫瘍に対する放射線治療のパラダイムシフト
    　Radixact（Synchrony）
    　　
    特集2　新規保険収載からわかる放射線治療の進歩
    　高精度放射線治療時代における体表面IGRTの役割
    　前立腺癌放射線治療におけるハイドロゲル使用指針
    　定位照射の適応拡大
    　遠隔放射線治療計画の現在と今後の展望
    　　
    特集3　粒子線施設の最先端
    　炭素線における高精度放射線治療へのアプローチ
    　国立がん研究センター中央病院の加速器BNCTシステム

    特集4　放射線治療の次なる取り組み
    　免疫と放射線治療
    　放射線治療におけるDeep learning　スムーズに導入するための準備
    　医学物理の視点から見るPrecision Medicineに向けた放射線治療
    　放射線治療の次なる取り組み　MR Linac
    　FLASH RT

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

【特集1 放射線治療機器の最新技術】

P.13 掲載の参考文献
1) Lim et al : Journal of Applied Clinical Medical Physics 20 (4), 2019
PubMed
2) Li et al : Frontiers in Oncology 9 (7), 2019
 
P.17 掲載の参考文献
1) 放射線治療計画ガイドライン 2016. 公益社団法人日本放射線腫瘍学会編
 
2) Shirato H et al : Physical aspects of a real-time tumor-tracking system for gated radiotherapy. Int J Radiat Oncol Biol Phys 48 (4) : 1187-95, 2000
PubMed
3) Tanabe S et al : Clinical commissioning of a new patient positioning system, SyncTraX FX4, for intracranial stereotactic radiotherapy. J Appl Clin Med Phys 19 (6) : 149-58, 2018
 
4) Takao S et al : Intrafractional Baseline Shift of Drift of Lung Tumor Motion During Gated Radiation Therapy With a Real-Time Tumor-Tracking System. Int J Radiat Oncol Biol Phys 94 (1) : 172-80, 2016
PubMed
5) Miyamoto N et al : Quantitative evaluation of image recognition performance of fiducial markers in real-time tumor-tracking radiation therapy. Phys Med 65 : 33-39, 2019
PubMed
P.20 掲載の参考文献
1) Brown, PD, Jaeckle, K, Ballman, KV, et al. Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases : A Randomized Clinical Trial. JAMA. 2016 ; 316 (4) : 401-9.
PubMed
2) Yamamoto, M, Serizawa, T, Shuto, T, et al. Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901) : a multi-institutional prospective observational study. The Lancet Oncology. 2014 ; 15 (4) : 387-95.
PubMed
3) Ohira, S, Ueda, Y, Akino, Y, et al. HyperArc VMAT planning for single and multiple brain metastases stereotactic radiosurgery : a new treatment planning approach. Radiat Oncol. 2018 ; 13 (1) : 13.
PubMed
4) Ohira, S, Sagawa, T, Ueda, Y, et al. Effect of collimator angle on HyperArc stereotactic radiosurgery planning for single and multiple brain metastases. Med Dosim. 2020 ; 45 (1) : 85-91.
PubMed
5) Minniti, G, D'Angelillo, RM, Scaringi, C, et al. Fractionated stereotactic radiosurgery for patients with brain metastases. J Neurooncol. 2014 ; 117 (2) : 295-301.
 
6) Inoue, HK, Seto, K, Nozaki, A, et al. Three-fraction CyberKnife radiotherapy for brain metastases in critical areas : referring to the risk evaluating radiation necrosis and the surrounding brain volumes circumscribed with a single dose equivalence of 14 Gy (V14). J Radiat Res. 2013 ; 54 (4) : 727-35.
 
7) Ohira, S, Kanayama, N, Komiyama, R, et al. Intra-fractional patient setup error during fractionated intracranial stereotactic irradiation treatment of patients wearing medical masks : comparison with and without bite block during COVID-19 pandemic. J Radiat Res. In press.
 
P.25 掲載の参考文献
1) Schnarr E et al : Feasibility of real-time motion management with helical tomotherapy : Med Phys 45 (4) : 1329-37, 2018
PubMed
2) 日本医学物理学会ほか : 呼吸性移動対策を伴う放射線治療に関するガイドライン (2019 https://www.jastro.or.jp/medicalpersonnel/guideline/kokyu2019.pdf)
 
3) Chen G. P. et al : Technical note : Comprehensive performance tests of the first clinical real-time motion tracking and compensation system using MLC and jaws : Med Phys 47 (7) : 2814-25, 2020
PubMed
4) Ferris William S et al : Evaluation of radixact motion synchrony for 3D respiratory motion ; Modeling accuracy and dosimetric fidelity : J. Appl Clin Med Phys 21 (9) : 96-106, 2020
PubMed
5) Physics Training Report : Synchrony on the Radixact Treatment Delivery System 1064193. E : 21, ACCURAY
 

【特集2 新規保険収載からわかる放射線治療の進歩】

P.31 掲載の参考文献
1) Padilla et al : A survey of surface imaging use in radiation oncology in the United States. J Appl Clin Med Phys : 1-8, 2019
 
2) Walter et al : Evaluation of daily patient positioning for radiotherapy with a commercial 3D surface-imaging system (Catalyst(TM)). Radiat Oncol 11 : 154, 2016
 
3) KUGELE et al : Surface guided radiotherapy (SGRT) improves breast cancer patient setup accuracy. J Appl Clin Med Phys 20 (9) : 61-68, 2019
PubMed
4) Stanley et al : Comparison of initial patient setup accuracy between surface imaging and three point localization : A retrospective analysis. J Appl Clin Med Phys 18 (6) : 58-61, 2017
PubMed
5) Ana Cravo Sa et al : Radiotherapy setup displacements in breast cancer patients : 3D surface imaging experience. Reports of practical oncology and radiotherapy 23 : 61-67, 2018
PubMed
6) Leong et al : Impact of use of optical surface imaging on initial patient setup for stereotactic body radiotherapy treatments. J Appl Clin Med Phys 20 (12) : 149-158, 2019
PubMed
7) Hattel et al : Evaluation of setup and intrafraction motion for surface guided whole breast cancer radiotherapy. J Appl Clin Med Phys 20 (6) : 39-44, 2019
PubMed
P.35 掲載の参考文献
1) N Mariados et al : Hydrogel Spacer Prospective Multicenter Randomized Controlled Pivotal Trial. Dosimetric and Clinical Effects of Perirectal Spacer Application in Men Undergoing Prostate IMRT. Int J Radiat Oncol Biol Phys 92 (5) : 971-7, 2015 Aug 1
 
2) DA Hamstra et al : Continued Benefit to Rectal Separation for Prostate RT. Final Results of a phase III trial. Int J Radiat Oncol Biol Phys 97 (5) : 976-985, 2017 Apr 1 ;
 
3) Lawrence I Karsh et al : Absorbable Hydrogel Spacer User in Prostate Radiotherapy. A Comprehensive Review of Phase 3 Clinical Trial Published Data UROLOGY 115 : 39-44,2018.
 
4) J. Motoya et al : How I Do It. Hydrogel spacer placement In men scheduled to undergo prostate scheduled to undergo prostate radiotherapy. The Canadian Journal of Urology TM 25 (2), 2018 April
 
5) Benjamin W et al : Hydrogel spacer distribution within the perirectal space in patients undergoing radiotherapy for prostate cancer. Impact of spacer symmetry on rectal dose reduction and the clinical consequences of hydrogel infiltration into the rectal wall. Practical Radiation Oncology 195-202, 2017 7
 
6) SpaceOARシステム添付文書
 
7) 日本放射線腫瘍学会 : 前立腺がんに対する放射線治療におけるSpaceOARシステムの適応使用指針, 2018
 
P.39 掲載の参考文献
1) Jim Zhong et al : Outcomes for patients with locally advanced pancreatic adenocarcinoma treated with stereotactic body radiation therapy versus conventionally fractionated radiation. Cancer 123 (18) : 3486-93, 2017
PubMed
2) Leila T Tchelebi et al : Conventionally fractionated radiation therapy versus stereotactic body radiation therapy for locally advanced pancreatic cancer (CRiSP) : An international systematic review and meta-analysis. Cancer 126 (10) : 2120-31, 2020
PubMed
3) Elaine Luterstein et al : Stereotactic MRI-guided Adaptive Radiation Therapy (SMART) for Locally Advanced Pancreatic Cancer : A Promising Approach. Cureus 10 (3) : e2324, 2018
PubMed
4) Arjun Sahgal et al : Reirradiation human spinal cord tolerance for stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 82 (1) 107-16, 2012
PubMed
5) David A Palma et al : Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers : Long-Term Results of the SABR-COMET Phase II Randomized Trial. J Clin Oncol 38 (25) : 2830-38, 2020
 
P.43 掲載の参考文献
1) 公益社団法人日本放射線腫瘍学会 : 遠隔放射線治療計画ガイドライン 2019 (改訂2版), 2019
 
2) 医学通信社 : 診療点数早見表 (2020年4月版), 2020
 
3) 日本放射線科専門医会ほか : 遠隔画像診断に関するガイドライン 2018, 2018
 
4) Varian Medical Systems : Temporary Use of Remote Desktop Connection for Varian Workstations. Customer Technical Bulletin, 2020
 

【特集3 粒子線施設の最先端】

P.50 掲載の参考文献
1) Li Y et al : Dose assessment for patients with stage I non-small cell lung cancer receiving passive scattering carbon-ion radiotherapy using daily computed tomographic images : A prospective study. Radiother Oncol 144 : 224-230,2020
 
2) Bhattacharyya T et al : First prospective feasibility study of carbon-ion radiotherapy using compact superconducting rotating gantry. Br J Radiol 92 : 1103,2019
PubMed
3) Shiba S et al : Use of a Si/CdTe Compton Camera for In vivo Real-Time Monitoring of Annihilation Gamma Rays Generated by Carbon Ion Beam Irradiation. Front. Oncol 10 : 635, 2020
PubMed
P.53 掲載の参考文献
1) International Atomic Energy Agency : Current status of neutron capture therapy. International Atomic Agency IAEATECDO-1223, 2002
 
2) Yamamoto T et al : Boron neutron capture therapy for glioblastoma. Cancer Lett 262 (2) : 143-52, 2008
PubMed
3) Sweet WH et al : The possible use of slow neutron plus boron 10 in therapy of intracranial tumors. Trans. Am. Nuerol. Assoc 56 : 60-3, 1951
 
4) Farr LE et al : Neutron capture therapy with boron in the treatment of glioblastoma multiforme. Am. J. Roentgenol Radium Ther. Nucl. Med. 71 (2) : 279-93, 1954
PubMed
5) Mishima Y et al : Treatment of malignant melanoma by single thermal neutron capture therapy with melanoma-seeking 10B-compound. Lancet 2 (8659) : 388-9, 1989
PubMed
6) 公益財団法人医用原子力技術研究振興財団 : 海外の照射設備及び実績情報提供 (検索ページ https://www.antm.or.jp/06_bnct/0301.html)
 
7) BNCT (ホウ素中性子捕捉療法) 実用化推進と拠点形成に向けた検討会議 : BNCT (ホウ素中性子捕捉療法) 実用化推進と拠点形成に向けて http://www.pref.osaka.lg.jp/attach/22976/00000000/torimatome.pdf, 2014
 
8) 平塚純一ほか : ホウ素中性子捕捉療法 (BNCT) 審査WG報告書, 平成30年度次世代医療機器・再生医療等製品評価指標作成事業, 1-86, 2019
 
9) Hirota Y et al : High linear-energy-transfer radiation can overcome radioresistance of glioma stem-like cells to low linear-energytransfer radiation. J. Radiat. Res 55 (1) : 75-83, 2014
 
10) Yamamoto T et al : Boron neutron capture therapy for newly diagnosed glioblastoma. Radiother. Oncol 91 (1) : 80-4, 2009
PubMed
11) Kawabata S et al : Boron neutron Capture Therapy for Newly Diagnosed Glioblastoma. J. Radiat. Res 50 : 51-60, 2009
PubMed
12) Yong Z et al : Boron neutron capture therapy for malignant melanoma : first clinical case report in China. Chin. J. Cancer Res 28 (6) : 634-40, 2016
PubMed
13) Hiratsuka J et al : Long-term outcome of cutaneous melanoma patients treated with boron neutron capture therapy (BNCT). J. Radiat. Res 1-7, 2020
 
14) Randers-Pehrson G et al : A practical target system for accelerator-based BNCT which may effectively double the dose rate. Med. Phys 25 (6) : 894-6, 1998
PubMed
15) Kim JK et al : Current research on accelerator-based boron neutron capture therapy in Korea. Nucl. Eng. Tec 41 (4) : 531-44, 2009
 
16) Nakamura S et al : Characterization of the relationship between neutron production and thermal load on a target material in an accelerator-based boron neutron capture therapy system employing a solid-state Li target. PLoS One 14 (11) : e0225587, 2019
 
17) Nakamura S et al : Dependence of neutrons generated by 7Li (p,n) reaction on Li thickness under free-air condition in accelerator-based boron neutron capture therapy system employing solid-state Li target. Phys. Med 58 : 121-130, 2019
 
18) Nakamura S et al : Evaluation of radioactivity in the bodies of mice induced by neutron exposure from an epi-thermal neutron source of an accelerator-based boron neutron capture therapy system. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci 93 (10) : 821-831, 2017
PubMed
19) Hirose K et al : Boron neutron capture therapy using cyclotron-based epithermal neutron source and borofalan (10B) for recurrent or locally advanced head and neck cancer (JHN002) : An open-label phase II trial. Radiother. Oncol. 155 : 182-187, 2021
PubMed

Rad Museum

P.60 掲載の参考文献
1) Postow MA et al : Immunologic correlates of the abscopal effect in a patient with melanoma. N Engl J Med 366 (10) : 925-31, 2012
 
2) Gray JE et al : Three-Year Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC-Update from PACIFIC. J Thorac Oncol 15 (2) : 288-293, 2020
 
3) oligometastasis (https://www.cancer.gov/publications/dictionaries/cancer-terms/def/oligometastasis)
 
4) Bauml JM et al : Pembrolizumab After Completion of Locally Ablative Therapy for Oligometastatic Non-Small Cell Lung Cancer : A Phase 2 Trial. JAMA Oncol 5 (9) : 1283-90, 2019
PubMed
5) Theelen WSME et al : Effect of Pembrolizumab After Stereotactic Body Radiotherapy vs Pembrolizumab Alone on Tumor Response in Patients With Advanced Non-Small Cell Lung Cancer : Results of the PEMBRORT Phase 2 Randomized Clinical Trial. JAMA Oncol 5 (9) : 1276-82, 2019
 
6) 新医薬品の「使用上の注意」の解説 (http://www2.astrazeneca.co.jp/product/di.asp?pr_kikaku_id=IMF120&di_type=03)
 
7) Nobashi TW et al : Clinical and radiological features of immune checkpoint inhibitor-related pneumonitis in lung cancer and non-lung cancers. Br J Radiol 93 (1115) : 20200409, 2020
PubMed
8) Chuang MT et al : Differentiating Radiation-Induced Necrosis from Recurrent Brain Tumor Using MR Perfusion and Spectroscopy : A Meta-Analysis. PLoS One 11 (1) : e0141438, 2016
PubMed
9) Kits A et al : Diagnostic accuracy of 11 C-methionine PET in detecting neuropathologically confirmed recurrent brain tumor after radiation therapy. Ann Nucl Med 32 (2) : 132-141, 2018
PubMed
10) Gianvincenzo Sparacia et al : Value of serial magnetic resonance imaging in the assessment of brain metastases volume control during stereotactic radiosurgery, World J Radiol 8 (12) : 916-921, 2016
PubMed
11) Goldberg SB et al : Pembrolizumab for management of patients with NSCLC and brain metastases : long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial. Lancet Oncol 21 (5) : 655-663, 2020
PubMed
12) 古田裕美ほか : 脳転移に対する抗PD-1抗体の治療効果と安全性について. 第59回日本肺癌学会学術集会 口演発表 O29-4
 
P.64 掲載の参考文献
1) Benjamens S et al : NPJ Digit Med. 2020 Sep 11 ; 3 : 118. doi : 10.1038/s41746-020-00324-0.
 
2) マッキンゼー緊急提言 デジタル革命の本質 : 日本のリーダーへのメッセージ https://www.mckinsey.com/jp/~/media/McKinsey/Locations/Asia/Japan/Our%20Work/Digital/Accelerating_digital_transformation_under_covid19-an_urgent_message_to_leaders_in_Japan-jp.pdf (2020/11/01 最終アクセス)
 
P.69 掲載の参考文献
1) Shiinoki T et al : Evaluation of a combined respiratory-gating system comprising the TrueBeam linear accelerator and a new real-time tumor-tracking radiotherapy system : a preliminary study. J Appl Clin Med Phys 17 (4) : 202-213, Erratum in : J Appl Clin Med Phys. 2017 Jul ; 18 (4) : 238, 2016
 
2) President Obama : State of the Union Address 2015, "Education Advocacy Impact," 2015 Annual Report of Personalized Medicine Coalition : 2, 2015
 
3) 国際個別化医療学会 : http://www.is-pm.org/profile/personalized-medicine.html
 
4) Hanazawa H et al : Clinical assessment of coiled fiducial markers as internal surrogates for hepatocellular carcinomas during gated stereotactic body radiotherapy with a real-time tumortracking system. Radiother Oncol 123 (1) : 43-48, 2017
PubMed
5) Sanuki N et al : Stereotactic body radiotherapy for small hepatocellular carcinoma : A retrospective outcome analysis in 185 patients. Acta Oncol 53 : 399-404, 2014
PubMed
6) Venkatesh SK et al : Magnetic resonance elastography of liver : technique, analysis, and clinical applications. J Magn Reson Imaging 37 (3) : 544-55, 2013
PubMed
7) Schaub SK et al : Functional Liver Imaging and Dosimetry to Predict Hepatotoxicity Risk in Cirrhotic Patients With Primary Liver Cancer. Int J Radiat Oncol Biol Phys 102 (4) : 1339-1348, 2018
 
8) Fujimoto K et al : Estimation of four-dimensional CT-based imaging biomarker of liver fibrosis using finite element method. Proc. SPIE 11313, Medical Imaging 2020 : Image Processing, 113130J, 2020
 
9) Kawano S et al : Assessment of elasticity of colorectal cancer tissue, clinical utility, pathological and phenotypical relevance. Cancer Sci 106 (9) : 1232-9, 2015
PubMed
10) Ang KK et al : Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363 (1) : 24-35, 2010
PubMed
11) Horsman M et al : Imaging hypoxia to improve radiotherapy outcome. Nat Rev Clin Oncol 9 : 674-687, 2012
PubMed
12) Butof R et al : Time in radiation oncology-keep it short! Radiother Oncol 106 (3) : 271-5, 2013
PubMed
13) Hosny A et al : Artificial intelligence in radiology. Nat Rev Cancer 18 (8) : 500-510, 2018
PubMed
14) Ruijiang L et al : Radiomics and Radiogenomics : Technical Basis and Clinical Applications (Imaging in Medical Diagnosis and Therapy)
 
15) Lou B et al : An image-based deep learning framework for individualizing radiotherapy dose. Lancet Digit Health 1 (3) : e136-e147, 2019
 
16) Nasief H et al : A machine learning based delta-radiomics process for early prediction of treatment response of pancreatic cancer. NPJ Precis Oncol 3 : 25, 2019
PubMed
17) Kawahara D et al : Assessment of biological dosimetric margin for stereotactic body radiation therapy. J Appl Clin Med Phys 21 (4) : 31-41, 2020
PubMed
18) Kawahara D et al : Optimization of irradiation interval for fractionated stereotactic radiosurgery by a cellular automata model with reoxygenation effects. Phys Med Biol 65 (8) : 085008, 2020
PubMed
19) Herskind C et al : Radiogenomics : A systems biology approach to understanding genetic risk factors for radiotherapy toxicity? Cancer Lett 382 (1) : 95-109, 2016
PubMed
20) Crispin-Ortuzar M et al : A radiobiological model of radiotherapy response and its correlation with prognostic imaging variables. Phys Med Biol 62 (7) : 2658-2674, 2017
PubMed
P.74 掲載の参考文献
1) Hunt A et al : Feasibility of magnetic resonance guided radiotherapy for the treatment of bladder cancer. Clin Transl Radiat Oncol 25 : 46-51, 2020
PubMed
2) Bruynzeel AME et al : A prospective single-arm phase 2 study of stereotactic magnetic resonance guided adaptive radiation therapy for prostate cancer : early toxicity results. Int J Radiat Oncol Biol Phys 105 (5) : 1086-1094, 2019
PubMed
3) Rudra S et al : Using adaptive magnetic resonance image-guided radiation therapy for treatment of inoperable pancreatic cancer. Cancer Med. 8 (5) : 2123-2132, 2019
PubMed
4) Placidi L et al : On-line adaptive MR guided radiotherapy for locally advanced pancreatic cancer : Clinical and dosimetric considerations. Tech Innov Patient Support Radiat Oncol 15 : 15-21, 2020
PubMed
5) Winkel D et al : Target coverage and dose criteria based evaluation of the first clinical 1.5T MR-linac SBRT treatments of lymph node oligometastases compared with conventional CBCT-linac treatment. Radiother Oncol 146 : 118-125, 2020
PubMed
6) Winkel D et al : Dosimetric feasibility of hypofractionation for SBRT treatment of lymph node oligometastases on the 1.5T MR-linac. Radiother Oncol 154 : 243-248, 2020
PubMed
7) Sim AJ et al : A review of the role of MRI in diagnosis and treatment of early stage lung cancer. Clin Transl Radiat Oncol 24 : 16-22, 2020
PubMed
8) Intven MPW et al : Online adaptive MR-guided radiotherapy for rectal cancer ; feasibility of the workflow on a 1.5T MR-linac : clinical implementation and initial experience. Radiother Oncol 154 : 172-178, 2020
PubMed
9) Padgett KR et al : Assessment of online adaptive MR-guided stereotactic body radiotherapy of liver cancers. Phys Med 77 : 54-63, 2020
PubMed
P.78 掲載の参考文献
1) Hornsey S et al : Unexpected dose-rate effect in the killing of mice by radiation. Nature 210 : 212-213, 1966
PubMed
2) Favaudon V et al : Ultrahigh dose-rate FLASH irradiation increases the differential response between normal and tumor tissue in mice. Sci Transl Med 6 : 245ra93, 2014
PubMed
3) Montay-Gruel P et al : Irradiation in a flash : Unique sparing of memory in mice after whole brain irradiation with dose rates above 100Gy/s. Radiother Oncol 124 : 365-369, 2017
 
4) Diffenderfer ES et al : Design, Implementation, and in Vivo Validation of a Novel Proton FLASH Radiation Therapy System. Int J Radiat Oncol Biol Phys 106 : 440-448, 2020
PubMed
5) Vozenin MC et al : The Advantage of FLASH Radiotherapy Confirmed in Mini-pig and Cat-cancer Patients. Clin Cancer Res 25 : 35-42, 2019
PubMed
6) Wilson JD et al : Ultra-High Dose Rate (FLASH) Radiotherapy : Silver Bullet or Fool's Gold? Front Oncol 9 : 1563, 2020
 
7) Kusumoto T et al : Significant changes in yields of 7-hydroxy-coumarin-3-carboxylic acid produced under FLASH radiotherapy conditions. RSC Adv 10 : 38709-38714, 2020
PubMed
8) Spitz DR et al : An integrated physicochemical approach for explaining the differential impact of FLASH versus conventional dose rate irradiation on cancer and normal tissue responses. Radiother Oncol 139 : 23-27, 2019
 
9) Bourhis J et al : Treatment of a first patient with FLASH-radiotherapy. Radiother Oncol 139 : 18-22, 2019
PubMed
10) Kokurewicz K et al : Focused very high-energy electron beams as a novel radiotherapy modality for producing high-dose volumetric elements. Sci Rep 9 : 10837, 2019
PubMed
11) van Marlen P et al : Bringing FLASH to the Clinic : Treatment Planning Considerations for Ultrahigh Dose-Rate Proton Beams. Int J Radiat Oncol Biol Phys 106 : 621-629, 2020
 
12) Maxim PG et al : PHASER : A platform for clinical translation of FLASH cancer radiotherapy. Radiother Oncol 139 : 28-33, 2019
PubMed
13) Eling L et al : Ultra high dose rate Synchrotron Microbeam Radiation Therapy. Preclinical evidence in view of a clinical transfer. Radiother Oncol. 139 : 56-61, 2019
PubMed

書評

最近チェックした商品履歴

Loading...